Training in psychedelic-assisted therapy for Indigenous communities
This study trains mental health professionals and community workers in psychedelic-assisted therapy, focusing on Indigenous healing practices. It aims to build capacity within Indigenous communities to address trauma and promote healing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older.
- Have experience working with Indigenous peoples or be a member of an Indigenous community.
- Have a significant connection to an Indigenous community (urban, rural, or on-reserve).
- Be fluent in English or an Indigenous language used in the study.
- Be available for all training and follow-up sessions.
- Have stable physical and mental health.
- Have a support system in place for emotional or psychological needs during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a meditation-based music program or a music-only program helps people prepare for a psychedelic experience. It's looking for people who have used psychedelics very little before and have no major health issues.
This study looks at how therapists’ personal experience affects their attitude and skills during substance-assisted therapy training. It’s mainly for therapists-in-training, and may help improve how future training and therapy are delivered safely.
This study tests if psilocybin-assisted group therapy can help people with moderate to severe PTSD. It is for veterans, first responders, female survivors of sexual violence, or Indigenous individuals.
This trial tests if MDMA-assisted therapy can help mental healthcare providers. It involves taking MDMA in a therapeutic setting while being recorded, and you must be trained in this type of therapy.
This study tests whether combining mindfulness training with a single dose of psilocybin (a psychedelic found in certain mushrooms) can help healthy adults. It aims to explore how these two approaches together might improve well-being.
This trial tests whether psilocybin (a psychedelic substance) combined with therapy can help adult children of genocide survivors who experience symptoms of trauma, depression, or anxiety. The goal is to see if this approach can reduce the emotional impact of intergenerational trauma.
Hear when a new Feasibility Studies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.